In a retrospective analysis utilising US administrative claims data, Hannah et al.,17 found that the implementation of CGM significantly reduced rates of hospitalisations related to diabetes‐induced hypoglycaemia or hyperglycaemia in insulin‐treated individuals with type 2 diabetes and CKD. The gene discussed is INS; the disease is chronic kidney disease.